ArticleFrontiers in endocrinology2026
Long-term mortality trends in patients with concurrent hernia and diabetes in the United States.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The coexistence of hernia and diabetes mellitus presents substantial clinical challenges due to diabetes-related impairment of wound healing, immune response, and vascular function. Despite this established pathophysiological relationship, national mortality trends for patients with both conditions remain inadequately characterized. Methods: This population-based study analyzed U.S. mortality data from 1999-2023. We included decedents aged ≥25 years with both hernia (ICD-10 K40-K46) and diabetes mellitus (E10-E14) listed as contributing causes of death. Age-adjusted mortality rates were calculated using the 2000 U.S. standard population. Joinpoint regression analyzed temporal trends stratified by demographic and geographic factors. Results: From 1999 to 2023, 7,128 U.S. deaths involved both hernia and diabetes. Overall age-adjusted mortality rates showed no significant long-term change, with a modest decline before 2019 followed by a sharp increase thereafter. Mortality rose more prominently among males, older adults, and individuals aged 65 years and above. Females and younger age groups experienced earlier declines but demonstrated clear reversals in recent years. Regional analyses revealed sustained declines in the Midwest, relative stability in the Northeast, and increasing mortality in the South and West. Racial and ethnic disparities persisted, with recent upward trends observed among Non-Hispanic White, Hispanic, and Non-Hispanic Black populations. Metropolitan areas showed greater mortality reductions than nonmetropolitan areas. Conclusions: Mortality involving both hernia and diabetes in the United States has remained largely stable over the past two decades but has increased markedly in recent years. Substantial disparities by sex, age, race, region, and urbanization persist. These findings highlight the need for improved perioperative risk management, equitable access to timely hernia repair, and integrated diabetes care, particularly for older adults and underserved populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.